Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-07

Clinical Trial Update: Ketamine to Treat Patients With Post-comatose Disorders of Consciousness [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates ketamine is being studied in Phase 2 and Phase 3 for treating patients with post-comatose disorders of consciousness, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University of Liege | Conditions: Disorder of Consciousness | Phase 2, Phase 3 | Status: RECRUITING